University of Turku has awarded Title of Docent to Dr. Ubaid Ullah Kalim
The University of Turku (Department of Life Technologies) has awarded the Title of Docent (Adjunct Professor) in molecular cell biology to Senior Research Fellow, Dr. Ubaid Ullah Kalim.
After PhD in 2012 from Jawaharlal Nehru University, New Delhi in the field of Immunology he has carried out postdoctoral research in the laboratory of Riitta Lahesmaa in Turku Bioscience Centre. His research focuses on epigenetic regulation of T cell activation and differentiation and molecular mechanisms of autoimmune disorders
-Over 90% disease associated SNPs lie in the noncoding regulatory region. Understanding the functional impact of the noncoding genome in health and disease may hold potential for novel therapies against human diseases, says Ubaid.
Recent Posts
- Early-career researchers invited to BioCity Pre-Symposium on 26 August. Registration is now open!Doctoral researchers at BioCity Turku are organising a pre-symposium on 26 August 2026, offering early-career Read moreApril 30, 2026
- 35th BioCity Symposium is arranged 27–28 August 2026. Registration is now open!This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August Read moreApril 14, 2026
- Turku Protein Core Opens Two New PositionsTurku Protein Core (TuProtCore) is seeking to fill two roles: a Project Specialist in Service Read moreApril 7, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026